TokenPost·

Larimar Therapeutics Estimates $128.7 Million in Cash at Quarter-End

Your call?
$128.7M
quarter-end cash

The preliminary, unaudited estimate covers cash, equivalents and marketable securities as of Sept. 30, 2026. Larimar projects its cash runway into late Q2 2027.

Share

More news